We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-29.74%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$243M
AUM Growth
-$369M
Cap. Flow
-$216M
Cap. Flow %
-88.84%
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94

Sector Composition

Rank Sector Weight
1 Financials 20.56%
2 Healthcare 19.87%
3 Real Estate 12.49%
4 Energy 9.44%
5 Materials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSM icon
151
Black Stone Minerals
BSM
$3.15B
$606K 0.25%
129,569
-122,693
-49% -$1.13M
TVTX icon
152
Travere Therapeutics
TVTX
$5.22B
$599K 0.25%
41,060
-3,465
-8% -$52.1K
SGEN
153
DELISTED
Seagen Inc. Common Stock
SGEN
$596K 0.25%
5,168
-436
-8% -$48.3K
LRFC
154
DELISTED
Logan Ridge Finance Corp
LRFC
$592K 0.24%
31,532
-10,959
-26% -$478K
OMER icon
155
Omeros
OMER
$845M
$587K 0.24%
43,917
-3,705
-8% -$49.3K
OFS icon
156
OFS Capital
OFS
$45.6M
$586K 0.24%
143,912
-38,881
-21% -$377K
MRNA icon
157
Moderna
MRNA
$21.8B
$578K 0.24%
19,304
-2,829
-13% -$65.1K
FOLD
158
DELISTED
Amicus Therapeutics
FOLD
$577K 0.24%
62,396
-5,265
-8% -$50K
EXEL icon
159
Exelixis
EXEL
$14.1B
$569K 0.23%
33,024
-2,786
-8% -$51K
EPR icon
160
EPR Properties
EPR
$4.87B
$566K 0.23%
23,350
-23,488
-50% -$1.35M
INN
161
Summit Hotel Properties
INN
$767M
$564K 0.23%
133,628
-173,627
-57% -$1.63M
ACAD icon
162
Acadia Pharmaceuticals
ACAD
$4.51B
$561K 0.23%
13,276
-1,120
-8% -$46.1K
BCSF icon
163
Bain Capital Specialty
BCSF
$826M
$558K 0.23%
61,348
-7,776
-11% -$134K
HALO icon
164
Halozyme
HALO
$9.89B
$558K 0.23%
30,996
-2,616
-8% -$49.7K
ICMB icon
165
Investcorp Credit Management BDC
ICMB
$11M
$551K 0.23%
226,348
-88,091
-28% -$530K
ALNY icon
166
Alnylam Pharmaceuticals
ALNY
$38B
$544K 0.22%
5,002
-422
-8% -$48.7K
PTCT icon
167
PTC Therapeutics
PTCT
$6.2B
$544K 0.22%
12,197
-1,029
-8% -$51.8K
CVM icon
168
CEL-SCI Corp
CVM
$20.3M
$536K 0.22%
1,548
-226
-13% -$82.6K
ALXN
169
DELISTED
Alexion Pharmaceuticals
ALXN
$507K 0.21%
5,644
-457
-7% -$44.9K
AMGN icon
170
Amgen
AMGN
$210B
$505K 0.21%
2,489
-210
-8% -$45.9K
NKTR icon
171
Nektar Therapeutics
NKTR
$2.34B
$494K 0.2%
1,844
-156
-8% -$48.3K
PFX icon
172
PhenixFIN
PFX
$83.1M
$480K 0.2%
41,337
-13,683
-25% -$462K
DKL icon
173
Delek Logistics
DKL
$3.12B
$478K 0.2%
52,514
-60,920
-54% -$1.47M
OKE icon
174
Oneok
OKE
$56.6B
$476K 0.2%
21,808
-25,711
-54% -$1.57M
INCY icon
175
Incyte
INCY
$25.6B
$470K 0.19%
6,424
-543
-8% -$41K

Similar funds

Virtus ETF Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, Virtus ETF Advisers held 504 positions worth $243M, down 60% from $612M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Virtus ETF Advisers withdrew a net $216M in Q1 2020, closing 94 positions and reducing 307 holdings. Its most notable exit was Reliance Steel & Aluminium, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Virtus ETF Advisers opened a new position in Newmont worth $1.82M.

  • Virtus ETF Advisers's largest Q1 2020 buy was Newmont: 40,138 shares worth $1.82M.
  • Virtus ETF Advisers added most to Oxford Square Capital in Q1 2020, an estimated $1.88M increase.
  • Virtus ETF Advisers's biggest Q1 2020 reduction was Air Products & Chemicals, cutting an estimated $3.72M.
  • Virtus ETF Advisers fully exited Reliance Steel & Aluminium in Q1 2020, selling an estimated $4.3M.
  • Virtus ETF Advisers's ten largest holdings make up 9.9% of its $243M portfolio in Q1 2020.
  • Virtus ETF Advisers opened 52 new positions and closed 94 in Q1 2020.
  • Virtus ETF Advisers's portfolio value fell 60% quarter-over-quarter to $243M.

Based on Virtus ETF Advisers's 13F filing for Q1 2020, filed 14 May 2020.